Mega Lifesciences Public Co. Ltd. engages in the manufacture and distribution of pharmaceutical, nutraceutical products, and consumer goods. It operates through the following segments: Maxxcare, Mega WeCare, and Original Equipment Manufacture (OEM). The Maxxcare segment markets, sells and distributes prescription pharmaceutical products, OTC, and FMCG products. The Mega WeCare segment develops, manufactures, markets, and sells nutraceutical products, prescription pharmaceutical products, and OTC products. The OEM segment engages in the manufacture of goods for third parties. The company was founded by Kirit Kumar Chimanla Shah in 1982 and is headquartered in Bangkok, Thailand.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company